Differential Effect of Ticagrelor Versus Prasugrel Maintenence Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease
Phase of Trial: Phase IV
Latest Information Update: 12 Jan 2017
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Prasugrel
- Indications Acute coronary syndromes; Coronary artery disease
- Focus Pharmacodynamics
- 08 Jan 2017 Status changed from recruiting to completed.
- 18 Aug 2015 Planned End Date changed from 1 Nov 2014 to 1 Dec 2015, as reported by ClinicalTrials.gov record.
- 18 Aug 2015 Planned primary completion date changed from 1 Nov 2014 to 1 Dec 2015, as reported by ClinicalTrials.gov.